Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02174640 · ClinicalTrials.gov registry record · NA
Acute Effects of Coffee Beverage on Postprandial Inflammation and Oxidative Stress - A Pilot Study
A NA study, sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology.
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT02174640: Completed NA study, sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology.
NCT02174640 is a NA study that has completed, run by Clinical Nutrition Research Center, Illinois Institute of Technology. The registered enrollment target is 9 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02174640, a NA study, has completed, sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology.
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
The primary objective is to test if acute supplementation with Coffee would improve antioxidant status, following consumption of a pro-oxidative high carbohydrate, high fat meal in over weight/ obese humans. Secondary objective is to determine the ability of coffee to modify postprandial inflammation in overweight/ obese humans.
Primary Outcome
The influence of coffee consumption on inflammation markers
Interventions
- DIETARY_SUPPLEMENT Water
- DIETARY_SUPPLEMENT Coffee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2014-06-15 |
| Est. Completion | 2014-12-16 |
| Phase | NA |
What the finished NCT02174640 record still lists
NCT02174640 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Water is the first listed.
NCT02174640 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02174640 about?
NCT02174640 is a clinical study titled "Acute Effects of Coffee Beverage on Postprandial Inflammation and Oxidative Stress - A Pilot Study". The primary objective is to test if acute supplementation with Coffee would improve antioxidant status, following consumption of a pro-oxidative high carbohydrate, high fat meal in over weight/ obese humans. Secondary objective is to determine the ability of coffee to modify postprandial inflammati...
What is the current status of trial NCT02174640?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2014-06-15. Estimated completion is 2014-12-16.
What interventions are being tested in trial NCT02174640?
The interventions under investigation include: Water (DIETARY_SUPPLEMENT), Coffee (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02174640?
This trial is sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology, which has 59 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02174640's enrollment target sits among peer trials
9 1975th of 2000 higher than 25 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI